Impact News +++ Beamr Solution Demonstrates up to 50% Improved Video Compression for Autonomous Vehicles, Accelerated... (GlobeNewswire EN) +++ BEAMR IMAGING Aktie +8,81%

VIATRIS Aktie

>VIATRIS Aktienkurs

8.918 EUR -0.3% (Tradegate)

Ask: 8.994 EUR / 3340 Stück

Bid: 8.95 EUR / 3360 Stück

Tagesumsatz: 2643 Stück

Realtime Kurs von 8 bis 22 Uhr!

VIATRIS Aktie über LYNX handeln

Intraday

1 Jahr

>VIATRIS Performance

1 Woche: -2,8%

1 Monat: +11,6%

3 Monate: +22,0%

6 Monate: -16,8%

1 Jahr: -15,7%

laufendes Jahr: -24,9%

>VIATRIS Aktie

Name:

VIATRIS INC. O.N.

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US92556V1061 / A2QAME

Symbol/ Ticker:

VIA (Frankfurt) / VTRS (NASDAQ)

Kürzel:

FRA:VIA, ETR:VIA, VIA:GR, NASDAQ:VTRS

Index:

S&P500

Webseite:

https://www.viatris.com/

Profil:

Viatris Inc. is a global healthcare company that p..
>Volltext..

Marktkapitalisierung:

10479.32 Mio. EUR

Unternehmenswert:

22511.59 Mio. EUR

Umsatz:

12139 Mio. EUR

EBITDA:

3402.47 Mio. EUR

Nettogewinn:

-2994.66 Mio. EUR

Gewinn je Aktie:

-2.51 EUR

Schulden:

12749.45 Mio. EUR

Liquide Mittel:

490.26 Mio. EUR

Operativer Cashflow:

1782.48 Mio. EUR

Bargeldquote:

0.09

Umsatzwachstum:

-15.87%

Gewinnwachstum:

-387.8%

Dividende je Aktie:

0.33 EUR

Dividendenrendite:

4.61%

Dividendenschätzung:

4.61%

Div. Historie:

23.05.25 - 0.105551995€
10.03.25 - 0.11071199€

>weitere anzeigen...

Insiderhandel:

1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 219.740 USD.

Suchwörter:

VIATRIS

Letzte Datenerhebung:

27.08.25

>VIATRIS Kennzahlen

Aktien/ Unternehmen:

Aktien: 1165.87 Mio. St.

Frei handelbar: 97.7%

Leerverk. Aktien: 3.11%

Rückkaufquote: 2.87%

Mitarbeiter: 32000

Umsatz/Mitarb.: 0.4 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: 7.47%

Bewertung:

KGV: -

KGV lG: 4.57

KUV: 0.87

KBV: 0.79

PEG-Ratio: -0.01

EV/EBITDA: 6.62

Rentabilität:

Bruttomarge: 39.16%

Gewinnmarge: -24.67%

Operative Marge: 8.41%

Managementeffizenz:

Gesamtkaprendite: -8.28%

Eigenkaprendite: -19.77%

>VIATRIS Peer Group

Es sind 601 Aktien bekannt.

>VIATRIS Chart & Kurs - NASDAQ

>VIATRIS News

14.08.25 - 05:01	Insiderhandel: Chief Executive Officer kauft Aktien von Viatris im Wert von 219740 USD (Insiderkauf)
	Smith, Scott Andrew - Vorstand - Tag der Transaktion: 2025-08-12...

12.08.25 - 22:06	Theravance Biopharma, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update (PR Newswire)
	YUPELRI® (revefenacin) net sales of $66.3 million, recognized by Viatris, increased 22% year-over-year1 Pivotal Phase 3 CYPRESS study enrollment on track to complete by late summer Completed sale of TRELEGY ELLIPTA royalty interest to GSK for $225 million TRELEGY year-to-date sales on......

12.08.25 - 12:12	FDA gives approval to Viatris for Iron Sucrose Injection (PBR)
	Iron deficiency anaemia (IDA) is a common complication in chronic kidney disease, and is linked with increased cardiovascular risks and mortality. Viatris' Iron Sucrose Injection is an intravenous The post FDA gives approval to Viatris for Iron Sucrose Injection appeared first on Pharmaceutical Business review....

11.08.25 - 16:12	Viatris wins FDA nod for generic iron sucrose injection targeting Daiichi’s Venofer (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

11.08.25 - 16:06	Viatris: FDA Approves First Generic Iron Sucrose Injection (AFX)
	WASHINGTON (dpa-AFX) - Viatris (VTRS) announced the FDA has approved Iron Sucrose Injection, USP, an intravenous iron replacement product used to treat iron deficiency anemia in adult and pediatri......

11.08.25 - 15:30	Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S. (PR Newswire)
	Approval is Another Milestone of Viatris' Ability to Successfully Develop Complex Generic Medicines Approval Granted with Competitive Generic Therapy Eligibility for 100mg/5mL and 200mg/10mL Strengths; Provides Eligibility for 180 Days of Exclusivity PITTSBURGH, Aug. 11, 2025 /PRNewswire/......

07.08.25 - 18:15	Viatris Stock Rises as Q2 Earnings & Revenues Beat Estimates (Zacks)
	VTRS beats on Q2 estimates with strength in branded drugs and growth in Greater China, lifting shares....

07.08.25 - 17:09	Viatris aims for top-half 2025 revenue and EPS guidance while advancing late-stage pipeline (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 16:45	Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics (Zacks)
	While the top- and bottom-line numbers for Viatris (VTRS) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

07.08.25 - 13:54	Viatris in charts: Q2 sees sequential growth across product categories and regions (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.08.25 - 13:48	Viatris Inc. Q2 Earnings Summary (AFX)
	WASHINGTON (dpa-AFX) - Below are the earnings highlights for Viatris Inc. (VTRS):Earnings: -$4.6 million in Q2 vs. -$326.4 million in the same period last year. EPS: $0 in Q2 vs. -$0.27 in the sam......

06.08.25 - 16:27	Viatris Q2 earnings on deck: What to expect (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

05.08.25 - 14:42	Viatris Stock: Analyst Estimates & Ratings (Barchart)
	Viatris has considerably underperformed the broader market over the past year, and analysts are cautious about the stock's prospects....

05.08.25 - 13:06	Viatris declares $0.12 dividend (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

05.08.25 - 13:01	Viatris Announces Quarterly Dividend (PR Newswire)
	PITTSBURGH, Aug. 5, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on August 4, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on September......

05.08.25 - 12:57	Viatris Announces Appointment of David Simmons to the Company′s Board of Directors (PR Newswire)
	PITTSBURGH, Aug. 5, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that David Simmons has been appointed as the newest member of Viatris' Board of Directors. Simmons has deep pharmaceutical industry experience, as well as extensive......

04.08.25 - 22:00	Viatris Poised to Report Q2 Earnings: What′s in Store for the Stock? (Zacks)
	VTRS braces for Q2 results as branded drug growth in Europe and China offsets generic headwinds in North America....

01.08.25 - 16:01	Viatris Announces Five Data Presentations on Novel Fast-Acting Meloxicam (MR-107A-02) at PAINWeek 2025 Conference (PR Newswire)
	Presentations to include efficacy, safety and opioid use reduction data in two different surgery models as well as pharmacokinetics data PITTSBURGH, Aug. 1, 2025 /PRNewswire/ -- Viatris (Nasdaq: VTRS), a global healthcare company, today announced that five abstracts from its Phase 3......

23.07.25 - 13:48	What to Expect From Viatris Next Quarterly Earnings Report (Barchart)
	Viatris is all set to release its fiscal second-quarter earnings next month, and analysts project a double-digit earnings drop....

18.07.25 - 14:18	Why Is Viatris Stock Falling In Pre-market? (AFX)
	WASHINGTON (dpa-AFX) - Viatris Inc. (VTRS) announced that a randomized, double-masked, vehicle-controlled, Phase 3 study to evaluate the efficacy and safety of pimecrolimus 0.3% ophthalmic ointmen......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wo es schon längere Zeit nicht gehagelt hat, läßt sich schon eine Hagelversicherung kaum verkaufen. - Komm.-Rat DDr. Norbert Zimmer

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram